CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income (loss)	$ 383,000	$ 2,620,000
Adjustments to reconcile net income (loss) to net cash:
Stock compensation expense	230,000	227,000
Foreign exchange loss (gain)	(33,000)	47,000
Depreciation and amortization	610,000	624,000
Deferred income taxes	(710,000)	(2,655,000)
Non-cash R&D services	200,000	205,000
Other	50,000	49,000
Other changes in assets and liabilities:
Accounts receivable, net	(811,000)	152,000
Inventories	(279,000)	(332,000)
Costs in excess of billings and unbilled receivables	472,000	328,000
Prepaid expenses and other assets	189,000	263,000
Accounts payable	(646,000)	(410,000)
Accrued expenses and other liabilities	123,000	(542,000)
Deferred revenue	(3,000)	(140,000)
Net cash from operating activities	(225,000)	436,000
Cash flows from investing activities:
Purchases of property, plant and equipment	(1,005,000)	(228,000)
Purchase of intangibles	(45,000)	(64,000)
Net cash from investing activities	(1,050,000)	(292,000)
Cash flows from financing activities:
Proceeds from issuance of common stock	8,000	8,000
Principal payments on capital leases	(50,000)	(55,000)
Proceeds from (payments of) equipment line of credit, net	281,000	0
Proceeds from (payments of) bank and subordinated debt, net	(277,000)	(354,000)
Net cash from financing activities	(38,000)	(401,000)
Effect of exchange rates on cash and cash equivalents	28,000	(51,000)
Net change in cash and cash equivalents	(1,285,000)	(308,000)
Cash and cash equivalents, beginning	2,415,000	2,607,000
Cash and cash equivalents, ending	1,130,000	2,299,000
Supplemental disclosures of cash flow information:
Cash paid during the year for: Interest	77,000	92,000
Cash paid during the year for: Tax payments (refunds)	5,000	3,000
Non cash activities:
Recapitalization of Xcede - conversion of non controlling notes payable to preferred stock	0	(3,103,000)
Subsidiary stock options issued to settle liabilities	0	75,000
Subsidiary debt issued to fund research activities	$ 0	$ 500,000